The fake medicine racket probe in Maharashtra has expanded as investigators examine a suspected multi-city supply chain involving counterfeit medicines. Authorities, including the Food and Drug Administration, are reviewing links between Nagpur, Pune, and Panvel-Kamothe operations. Ritesh Thombre is being examined in connection with the alleged distribution network, while other individuals and entities have also been named in the complaint material. A recent seizure of suspected counterfeit injections has intensified scrutiny. Officials are tracing manufacturing, billing, and distribution channels, though no final findings have been confirmed, and all allegations remain under investigation.

Fake Injection Racket Exposed: Panvel-Kamothe Pharma Owner Ritesh Thombre Under Scanner in Maharashtra Probe

Investigators examining an alleged fake medicine network say links have emerged between Nagpur and Pune cases. Authorities are now scrutinising the wider supply chain and distribution trail.

A suspected fake injection racket spanning multiple cities has come under sharper focus after investigators linked Panvel-Kamothe businessman Ritesh Thombre to separate Maharashtra inquiries.

According to reports, Ritesh Thombre, associated with RRT Pharma in Panvel-Kamothe, is being examined as a possible key state-level link in the network.

Officials are investigating whether counterfeit medicines were routed through multiple distributors before reaching wholesalers and retailers across Maharashtra, including Pune and surrounding areas.

Authorities have also noted that earlier criminal proceedings were reportedly registered against Ritesh Thombre in connection with related allegations.

Nagpur Raid Reveals Large Stock Of Suspected Counterfeit Injections

The latest scrutiny intensified after Food and Drug Administration teams reportedly recovered a substantial stock of suspected fake medicines in Nagpur.

The seizure was made at Hitanshi Pharmaceuticals in Tulsinagar, Nagpur, where officers allegedly found counterfeit stock during inspection proceedings.

Investigators claim the fake stock involved an injection branded as “Alburel,” allegedly prepared under the misuse of another company’s identity.

According to the inquiry, the counterfeit “Alburel” stock was allegedly manufactured in Chandigarh at Glasko Pharmaceuticals, linked to Raju Mishra.

Officials suspect the stock was then moved through out-of-state distributors before eventually reaching channels connected to Ritesh Thombre.

Sources further alleged that, except for the Chandigarh unit, transactions at other locations were supported using false invoices.

Delhi Broker Danish Khan Also Named In Probe

Investigators have also identified Delhi-based pharmaceutical broker Danish Khan as a person of interest in the alleged supply chain.

Authorities are examining whether Danish Khan played an intermediary role in the movement, coordination, billing, or distribution of suspected counterfeit medicines.

During questioning linked to the Nagpur case, officials reportedly asked Ritesh Thombre about the origin of counterfeit Alburel stock.

Sources claimed Ritesh Thombre stated that his business operations had already closed, while distancing himself from active transactions.

Authorities have not publicly released the complete statement record or final findings arising from that questioning process.

Pune Case Names Multiple Business Figures

Separate proceedings in Pune reportedly name Ritesh Thombre and Danish Khan alongside several business-linked individuals and entities.

Those named include Shriram Healthcare owner Shriram Nandkishor Chandak and RSL owner Rajesh Shantaram Jog from Sadashiv Peth.

Rajesh Shantaram Jog’s business associate, Shri Shailam Rajayya Gatla of Worli BDD Chawl, Mumbai, has also been mentioned in reports.

Prizem Traders was additionally cited in the complaint alleging conspiracy to distribute suspected counterfeit Alburel injections in Pune markets.

Authorities are investigating whether coordination between suppliers and distributors enabled the large-scale circulation of the questioned product.

Also Read: ₹500 Crore Investment Scam: Karivadekar Bank Trail Deepens.

July To October 2025 Sales Period Under Review

Investigators believe large quantities of suspected fake injections were sold to customers between July 11 and October 2025.

Officials say the alleged sales were carried out through channels involving Shriram Nandkishor Chandak and Rajesh Shantaram Jog.

The Pune case was reportedly registered following a complaint by Drug Inspector Shrutika Jadhav from the FDA joint commissioner’s office.

Despite earlier allegations, direct enforcement action against Ritesh Thombre was reportedly not taken during the initial Pune phase.

What Happens Next In Maharashtra Fake Drug Probe

With Nagpur and Pune evidence trails now overlapping, investigators are reassessing the full scale of the suspected racket.

Officials are expected to compare invoices, stock movement records, warehouse links, call data, and financial transactions across cities.

No court has yet declared guilt against any named person in the current reports, and all allegations remain subject to investigation.

The case has triggered broader concern over medicine safety, regulatory enforcement, and counterfeit pharmaceutical risks for patients across Maharashtra.

Previous controversies linked to Ritesh Rohidas Thombre and RRT Pharma have surfaced in multiple counterfeit medicine investigations in Maharashtra, particularly concerning the alleged circulation of fake Alburel injections. Reports from Pune and Nagpur state that regulatory authorities and police agencies examined supply chains connected to RRT Pharma after suspected spurious medicines were seized during raids.

In an earlier Pune-linked case, officials alleged that Ritesh Rohidas Thombre, proprietor of RRT Pharma, failed to produce complete purchase and sales records during questioning. Investigators reportedly searched the linked premises but did not recover stock at that stage. Authorities also alleged that medicines had been procured without standard billing documentation, prompting further scrutiny of business transactions.

The Pune FIR reportedly named multiple distributors and traders, including RRT Pharma, after samples of Alburel were declared spurious by government analysts. Investigators alleged that counterfeit stock moved through a chain involving firms in Pune, Mumbai, Nagpur, Raigad, Delhi, and Chandigarh.

More recently, Nagpur police registered another case involving a suspected spurious medicines racket where distributors across several cities were named. Reports again referenced links to the wider network under investigation.

No final conviction has been cited in these reports against Ritesh Rohidas Thombre in the matters referenced above. All allegations remain subject to ongoing investigation and judicial process.

Readers Appeal

Unmesh Gujarathi has exposed share market scams, fake medicine rackets, corruption cases, land frauds, builder scams, financial frauds, cyber crimes, extortion networks, illegal businesses, and public-interest scandals. If you have documents, evidence, or verified information about any scam or wrongdoing, contact his team confidentially on 9322755098.

Editorial Note:

This article is based on publicly available FIR records, court case references, and reports published by multiple media organisations. The information is presented in the context of ongoing investigations and public interest reporting. Sprouts News does not make any judicial determination regarding the individuals mentioned and does not intend to defame any person or organisation. Any individual seeking clarification or wishing to provide an official response may contact the editorial team with verifiable documentation. The information is presented for journalistic and informational purposes.